The Genomic Grade Index predicts postoperative clinical outcome in patients with soft-tissue sarcoma

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Annals of Oncology

• Publication date

  2018-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/annonc/mdx699PMID 29069276
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Soft tissue and visceral sarcomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2018cited by this paper
• The CINSARC signature as a prognostic marker for clinical outcome in multiple neoplasms

  2017cited by this paper
• Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2014cited by this paper
• Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

  2012cited by this paper
• Genomic Grade Index predicts postoperative clinical outcome of GIST

  2012cited by this paper
• Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial.

  2012cited by this paper
• Expression profiling of liposarcoma yields a multigene predictor of patient outcome and identifies genes that contribute to liposarcomagenesis.

  2011cited by this paper
• Effect of adjuvant chemotherapy on survival in FNCLCC grade 3 soft tissue sarcomas: a multivariate analysis of the French Sarcoma Group Database.

  2010cited by this paper
• Validated prediction of clinical outcome in sarcomas and multiple types of cancer on the basis of a gene expression signature related to genome complexity

  2010cited by this paper
• The CINSARC signature: Prognostic and predictive of response to chemotherapy?

  2010cited by this paper
• Improvement of the clinical applicability of the Genomic Grade Index through a qRT-PCR test performed on frozen and formalin-fixed paraffin-embedded tissues

  2009cited by this paper
• Genomic grade index is associated with response to chemotherapy in patients with breast cancer.

  2009cited by this paper
• Effect of adjuvant chemotherapy on survival in FNCLCC grade 3 soft tissue sarcomas: A multivariate analysis of the French Sarcoma Group database.

  2009cited by this paper
• Grading of soft tissue sarcomas: review and update.

  2009cited by this paper
• A Three-Gene Signature for Outcome in Soft Tissue Sarcoma

  2009cited by this paper
• Deep sampling of the Palomero maize transcriptome by a high throughput strategy of pyrosequencing

  2009cited by this paper
• Discovery of molecular subtypes in leiomyosarcoma through integrative molecular profiling

  2009cited by this paper
• A systematic meta‐analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft‐tissue sarcoma

  2008cited by this paper
• Opportunities for improving the therapeutic ratio for patients with sarcoma.

  2007cited by this paper
• Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis.

  2006influential reference
• A Gene Expression Signature Associated with Metastatic Outcome in Human Leiomyosarcomas

  2004cited by this paper
• BMC Genomics BioMed Central

  2004cited by this paper
• Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas

  2001cited by this paper
• Gene expression profiling of cancer by use of DNA arrays: how far from the clinic?

  2001cited by this paper
• Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma.

  1997cited by this paper
• Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Sarcoma Meta-analysis Collaboration.

  1997cited by this paper
• The grading of soft tissue sarcomas results of a clinicohistopathologic correlation in a series of 163 cases

  1984cited by this paper

• Progress in histology specific treatments in soft tissue sarcoma

  2024cites this paper
• Prognostic characteristics of a six-gene signature based on ssGSEA in sarcoma

  2024cites this paper
• The spectrum and significance of secondary (co‐occurring) genetic alterations in sarcomas: the hallmarks of sarcomagenesis

  2023cites this paper
• Gene fusions in poroma, porocarcinoma and related adnexal skin tumours: An update

  2023cites this paper
• The role of perioperative chemotherapy in primary high-grade extremity soft tissue sarcoma: a risk-stratified analysis using PERSARC.

  2022cites this paper
• Prediction tools for the personalized management of soft-tissue sarcomas of the extremity

  2022cites this paper
• The Cancer Genome Atlas: Impact and Future Directions in Sarcoma.

  2022cites this paper
• Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature

  2022cites this paper
• Complexity index in sarcoma and genomic grade index gene signatures in rhabdomyosarcoma of pediatric and adult ages

  2021cites this paper
• Unmet Medical Needs and Future Perspectives for Leiomyosarcoma Patients—A Position Paper from the National LeioMyoSarcoma Foundation (NLMSF) and Sarcoma Patients EuroNet (SPAEN)

  2021cites this paper
• Predictive and prognostic transcriptomic biomarkers in soft tissue sarcomas

  2021cites this paper
• What is the standard indication of adjuvant or neoadjuvant chemotherapy in localized soft-tissue sarcoma?

  2021cites this paper
• Targeted and immuno-based therapies in sarcoma: mechanisms and advances in clinical trials.

  2021cites this paper
• EJSO educational Special issue from the TARPSWG - Standard medical treatment and new options in retroperitoneal sarcoma.

  2021cites this paper
• Targeting Lymphotoxin Beta and Paired Box 5: a potential therapeutic strategy for soft tissue sarcoma metastasis

  2021cites this paper
• Detection of tetraploidization in chromophobe renal cell carcinoma: Insights and pitfalls

  2020cites this paper
• Defining Which Patients Are at High Risk for Recurrence of Soft Tissue Sarcoma

  2020cites this paper
• Less is more: A systematic review and meta-analysis of the outcomes of radical versus conservative primary resection in anorectal melanoma.

  2020cites this paper
• The impact of chemotherapy on survival of patients with extremity and trunk wall soft tissue sarcoma: revisiting the results of the EORTC-STBSG 62931 randomised trial.

  2019cites this paper
• Validation of Neutrophil Count as An Algorithm-Based Predictive Factor of Progression-Free Survival in Patients with Metastatic Soft Tissue Sarcomas Treated with Trabectedin

  2019cites this paper
• Prognostication in Mesenchymal Tumors: Can We Improve?

  2019cites this paper
• Pleomorphic Sarcomas: The State of the Art.

  2019cites this paper
• The Future of Radiation Oncology in Soft Tissue Sarcoma

  2018cites this paper
• Towards the standard use of (neo)adjuvant chemotherapy in selected localised soft tissue sarcoma at high risk of relapse: are we finally getting there?

  2018cites this paper
• Outcome prediction in patients with localized soft tissue sarcoma: which tool is the best?

  2018cites this paper
• Selection of Patients With Localized Extremity Soft Tissue Sarcoma for Treatment With Perioperative Chemotherapy

  2018cites this paper